South Australia to ban phones, personal devices in childcare centres
Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
An Australian state will become one of the first to ban all personal devices - including mobile phones - in early learning centres. Photo / 123rf
South Australia will be one of the first Australian states to ban the use of personal mobile phones in childcare centres.
The regulations will be implemented across all childcare and early learning centres in an effort to strengthen safety and 'better protect young children across the state'.
The South Australian and Victorian state governments are among the first to implement the National Model Code, which includes the ban of mobile phones, tablets, iPads, and other devices capable of taking photos or videos, personal storage or files transfer.
South Australia's Education Minister Blair Boyer said: 'The safety and wellbeing of our children is paramount, and we are working quickly to strengthen the safety requirements for long day care services and preschools.
'All providers in South Australia must now ensure they have provided their policies and procedures to ban the use of personal mobile devices to our independent regulator.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
1News
21 hours ago
- 1News
Australian researchers say psychedelics could benefit terminally ill
Psychedelics could significantly alleviate the anguish, debilitating depression and death-anxiety often experienced by the terminally ill but its implications could be much more profound, clinicians say. In an Australian-first, a near three-year clinical trial examined the use of psilocybin — a naturally occurring compound found in some species of mushrooms — in combination with psychotherapy for dozens of people living with crippling, life-threatening illness. Psychologist Margaret Ross and psychiatrist Dr Justin Dwyer, who co-led the study, said the drug was able to ease the debilitating death-related anxiety and depression experienced by many palliative care patients. "When you're told you're going to die, your entire world collapses... it's the final unknowable frontier," Dwyer told AAP. "Many people find themselves stranded in this endless moment of waiting to die, just waiting for the axe to fall... with that, comes crushing feelings of despair." ADVERTISEMENT There are few treatments available for people experiencing distress around dying. Between January 2020 and October 2023, 35 terminally ill participants were given psilocybin over two eight-hour treatment sessions several weeks apart at St Vincent's Hospital in Melbourne. Both sessions were accompanied by nine psychotherapy sessions before and after dosing. The trial's findings have been published in General Hospital Psychiatry. A Gisborne-based company is pioneering research into psychoactive compounds that could alter brain receptors and prompt positive behavioural changes. (Source: 1News) Those in the study reported significant reductions in depression and anxiety as well as sustained gains in mood, outlook, and wellbeing within 24 hours of treatment. But Dwyer said these results only touched the surface. ADVERTISEMENT "Many patients reported having a transformational experience," he said. "They felt they had a sense of being back in life in a richer, more vibrant way. "One patient said they felt saturated with a divinity that wasn't there before." While results were promising, the clinicians emphasised psychedelic-assisted therapy was still in its early stages. "It didn't work for everyone," Dwyer cautioned. "And it shouldn't be a treatment open slather for all." Melbourne psychiatrist Eli Kotler was among a handful of Australian doctors able to prescribe psychedelic medication and agreed the treatment needed to be used cautiously. ADVERTISEMENT Kotler said psychedelics such as psilocybin helped with human suffering, a condition he believed was at the heart of the St Vincent's study for those confronting dying. "In many ways, mental health has lost it's heart and soul and runs the risk of treating psychiatric diagnoses rather than helping humans heal," he told AAP. Psilocybin appeared to work by changing the way parts of the brain connected and interacted. Dwyer said there were theories but nobody really knew how the drug worked. In recent years, there has been an explosion of interest in the therapeutic effects of psilocybin, with half-a-dozen studies underway in Australia, and many more in the pipeline. Psilocybin and MDMA have been able to be prescribed by approved psychiatrists for certain mental health conditions since July of 2023.
Otago Daily Times
a day ago
- Otago Daily Times
Opinion: New Zealand needs more doctors, but is a new medical school the solution?
New Zealand desperately needs more doctors, especially general practitioners. However, the government's own analysis shows that its flagship solution — building a brand-new medical school in Waikato — is deeply flawed. The government said a Waikato Medical School would be a cheaper, faster route to training more doctors. However, the detailed business case — which is meant to ensure government projects deliver value for money and was released nearly a week later — shows this decision was based on misleading assumptions and omissions. Firstly, the government's pitch hinges on the Waikato school being a four-year graduate-entry programme, supposedly cheaper than the current six-year degrees at Otago and Auckland universities. What they conveniently omit is that students must first complete a minimum three-year bachelors degree before even starting. The government claimed running costs will be cheaper because of a shorter degree but had never considered trialling the four-year graduate model at Otago or Auckland, where infrastructure and proven teaching expertise already exist. Why build an entirely new institution rather than simply expanding existing, successful schools? Furthermore, the government modelled its plan on an Australian programme, assuming it would increase the number of GPs working rurally here. That's a risky assumption. The business case estimated that 38% of Waikato graduates would become general practitioners, compared to 23% if intake was increased at Auckland and Otago, and 33% through a joint rural training programme. This is speculation and contradicted by Prof Warwick Bagg, Dean of the University of Auckland's medical school, who said current programmes already had around 35% of graduates working as a GP eight years after graduation. There are also questions around what impact Waikato will have on Otago's existing rural programme and what effect it will have on placements already aligned with the university. The Waikato medical school was pitched to National as a political "gift" and the government has cherry-picked facts and overlooked other options. For example, Otago and Auckland universities could expand their intakes now, producing more doctors faster in proven, established environments that require only increased funding — not costly new infrastructure. Christopher Luxon's government is out of touch, prioritising pet projects, instead of focusing on the delivering what New Zealand needs. Rather than chasing a political headline, the government could look to support and expand the medical schools we already have. Our health system and patients deserve no less.
Techday NZ
4 days ago
- Techday NZ
OneMRI raises AUD $2.5m to expand preventive MRI scan service
Australian startup OneMRI has raised AUD $2.5 million in seed capital to expand its national service offering preventive whole-body MRI scans for early detection of a wide range of health conditions. Funding round The seed round was oversubscribed, with participation from investors including OIF Ventures, TEN13, Antler, Salus Ventures, AfterWork Ventures, Archangel Ventures, Black Sheep Capital, Prtnr, Larsen Ventures, Tribe Global Ventures, as well as several clinicians and radiologists. The funding aims to support OneMRI's growth across Australia to meet increasing consumer interest in proactive health management. OneMRI was founded in October 2024 by Dr. Vu Tran and Andrew Barnes, known for their work at Go1, alongside entrepreneur Gopi Sara. The company markets itself as Australia's first and only national provider of whole-body MRI scans, designed to enable early detection of over 500 potential health conditions including cancers, metabolic disorders, benign growths, autoimmune conditions such as MS, spinal degeneration, and brain aneurysms. Preventive health model The clinical approach at OneMRI is supported by research and development, with scan reviews by radiologists and consultations with doctors to ensure clinical rigour. The scans are intended to complement, not replace, more targeted diagnostic tests. Gopi Sara, OneMRI Co-founder and Chief Executive Officer, described the firm's emphasis on an ethical and patient-focused process. "OneMRI's process is genuinely customer-centric, with a rigorous eligibility and informed consent framework. We have a duty of care to every individual, which is why thoughtful screening is at the core of our approach. Every appointment includes both a pre- and post-scan consultation with qualified clinicians and dedicated care coordinators - ensuring patients fully understand the process, their results and what potential next steps might look like." OneMRI partners with radiology providers such as Scan Medical and Pinnacle Medical Imaging, and collaborates with healthcare professionals and wellness brands including The Banyans, Evergreen Doctors, Melbourne Functional Medicine, and Longev. By partnering with underutilised clinics, the company utilises MRI machines operating below capacity without increasing strain on existing healthcare resources. Sector growth and patient access Dr. Vu Tran, Co-Founder and Head of Medical, OneMRI, highlighted the increasing relevance of preventive health and technology in the sector. "Wellness and preventive health are only going to grow as sectors - and technology will play a critical role in that evolution. Right now, radiology is one of the most underutilised tools in preventive care. The 'health curious' increasingly want autonomy, access, and answers. Individuals should have the agency to take a proactive approach to their health, and whole-body MRI scans are one of the safest ways to do that - offering a multi-system snapshot in a single, radiation-free investigation. Our aim is to increase OneMRI's footprint and accessibility through market growth and product innovation. We've already seen everyday Australians, from schoolteachers to nurses, benefit from our scans, and believe that we have an important part to play as more people take a proactive approach to their long-term health." Early adopters of the service have already identified previously undetected life-threatening conditions. Michelle, 49, a Life Coach from Sydney, commented on her reasons for participating: "I did a preventive MRI not out of fear, but because I believe in being proactive with my health. It gave me peace of mind and reminded me how important it is to listen to our bodies and take care of ourselves before something feels wrong." David Shein, Partner at OIF Ventures, remarked on the investment: "Investing in OneMRI is not only an exceptional opportunity to back a fast-growing sector, but it's also a way for us to support improved and more accessible care for Australians over time. I've been very impressed with what the team has achieved to date, and anticipate strong future growth for the company." Current operations and expansion OneMRI currently provides its services in Brisbane, the Gold Coast, Perth, Sydney, Newcastle, and Melbourne, with further locations expected to be added as expansion continues. The company is also preparing to offer its services across the Asia Pacific region in future international growth plans.
